Ingredient or product comparison
Using GHK-Cu for Wound Healing Research Evidence: Protocol Comparison
Bioavailability at Wound Site 60–75% (measured by copper deposition in tissue samples) 85–90% (direct delivery to dermis) 15–25% (hepatic first-pass degradation reduces local concentration) Topical formulations achieve therapeutic levels (1–10 µM) with minimal
This source-based comparison does not add ratings or recommend a winner.
- Bioavailability at Wound Site
- 60–75% (measured by copper deposition in tissue samples)
- 85–90% (direct delivery to dermis)
- 15–25% (hepatic first-pass degradation reduces local concentration)
- Topical formulations achieve therapeutic levels (1–10 µM) with minimal systemic absorption. Preferred for localized research models
- Onset of VEGF Upregulation
- 18–24 hours post-application
- 6–12 hours post-injection
- 24–48 hours (delayed due to distribution kinetics)
- Subcutaneous injection produces fastest angiogenic response, critical for ischemic wound models
- Inflammatory Modulation
- Moderate (reduces surface cytokine expression but limited dermal penetration)
- Strong (reaches deep dermal inflammatory infiltrates)
- Variable (depends on wound perfusion status)
- Injection protocols show 40% greater TNF-α reduction at 48 hours vs topical in deep tissue injury models
- Collagen Type I/III Ratio at Day 21
- 3.2:1 (improved vs 2:1 baseline)
- 4.1:1 (optimal ratio for tensile strength)
- 2.8:1 (inconsistent delivery to wound bed)
- Subcutaneous delivery consistently produces mature collagen architecture matching uninjured tissue
- Practical Considerations
- Non-invasive, suitable for epithelial wounds, requires daily reapplication
- Single or repeated injections, requires sterile technique, risk of injection site reaction
- Rarely used in wound healing research (systemic side effects, poor wound targeting)
- Topical for surface wounds, injection for full-thickness or chronic ulcer models
- Bottom Line
- Best for partial-thickness wounds and research on epithelial migration. Limited depth penetration restricts efficacy in full-thickness models
- Gold standard for deep tissue wound research. Direct dermal delivery ensures consistent local concentration at the injury site
- Not recommended for wound healing research due to poor bioavailability at target tissue and inability to achieve therapeutic local concentrations
- Choose topical for epithelialization studies, subcutaneous for collagen remodeling and angiogenesis research